Introduction {#sec1}
============

Most cardiovascular risk factors such as hypertension, diabetes and endothelial dysfunction may contribute to alteration in the structure and function of arterial blood vessels.[@bib1] Arterial stiffness represents deleterious vascular phenotypes in some pathophysiological condition such as diabetes, atherosclerosis and kidney disease, in this reason it is considered as an important surrogate marker to predict future cardiovascular outcomes.[@bib2]^,^[@bib3] Previous evidence has shown that arterial walls stiffen with age because aging process induced alterations in arterial wall tissue.[@bib4]^,^[@bib5] It has also been established that arterial stiffness increases with age in healthy individuals without overt cardiovascular disease (CVD), suggesting increasing age may be an independent risk factor for arterial stiffening.[@bib5] To measure arterial stiffness, brachial-ankle pulse wave velocity (baPWV) has become a popular method because of an advantage of convenience to use.[@bib6] Previous studies have shown that baPWV is highly related to risk factors for CVD and aerobic capacity.[@bib7]^,^[@bib8]

Both acute and chronic aerobic exercise has been suggested to reduce arterial stiffness by enhancing vascular endothelial function as well as by effectively acting on structural and functional changes in blood vessels.[@bib5]^,^[@bib9], [@bib10], [@bib11] Of these studies, Vaitkevicius et al. showed that a progressive increase in arterial stiffness with advancing age (96 men 21--91 years old and 50 women 26--96 years old) and the age-associated arterial stiffness is inversely related to exercise capacity measured by maximal aerobic capacity (VO~2max~), suggesting arterial stiffness may be delayed by regular aerobic exercise.[@bib5] The maximum oxygen uptake indicates the oxygen transport capacity of cardiovascular system and the ability of the tissue to utilize oxygen. The parameter is highly correlated with the cardiopulmonary endurance and is generally improved by endurance training and decreased with advancing age.[@bib12] Previous evidence has shown an inverse relationship between cardiorespiratory fitness and CVD mortality, suggesting improving aerobic fitness is a key factor in cardiovascular health.[@bib13]^,^[@bib14] Graded Exercise Test (GXT) is a typical method to measure maximal oxygen uptake and is often used to examine the subject\'s risk of heart disease and cardiopulmonary endurance.[@bib15]^,^[@bib16] Augustine et al. have suggested that aortic stiffness is inversely associated with maximal oxygen consumption in the middle aged women with central obesity.[@bib17] In this study, the authors suggested CVD risk factors such as insulin resistance, systemic inflammation and hemodynamic mechanical stress may be associated with aortic stiffness.[@bib17] In addition, Tomoto et al. indicated that both baPWV and heart-ankle PWV are inversely correlated to aerobic capacity in wide range of age in the healthy men (18--64 years) and Arena et al. showed a relationship between VO~2max~ and aortic wave velocity in healthy middle aged subjects.[@bib6]^,^[@bib18] Taken together, aerobic capacity and arterial stiffness may be negatively correlated in disease condition such as obesity and advancing age. However, there is very limited research on the relationship between arterial stiffness and aerobic capacity in healthy young adults. Specifically, since Tomoto group showed various aerobic capacity levels and wide range of arterial stiffness in their various range of age group in 82 healthy men (18--64 years),[@bib6] it is needed to investigate the relationship between arterial stiffness and aerobic capacity in healthy young men. In this regard, we investigated whether arterial stiffness is correlated with maximal oxygen consumption in young adults. Further, we also investigated the relationship between arterial stiffness and CVD risk factors (blood biomarkers including glycated hemoglobin (HbA1c), glucose and lipid profiles).

Methods {#sec2}
=======

Participants {#sec2.1}
------------

We calculated the sample size of this pilot study using G power program based on the results of a previously published study.[@bib6] The total sample size was calculated to be at least 14 subjects. A healthy, young group comprising 23 subjects: 13 men (22.9 ± 0.7 years) and 10 women (23.6 ± 0.4 years) were participated in this study. We excluded subjects with a previous history of diagnosis or medication for hypertension and clinical CVD including ischemic heart disease. All subjects underwent both GXT by treadmill and evaluation of arterial stiffness by baPWV. All subjects were informed about the benefits and possible risks of the study and were participated in the study after signing a written consent form. This experimental protocol was reviewed and approved by the Institutional Review Board of Incheon National University.

Anthropometric and blood pressure measurement {#sec2.2}
---------------------------------------------

All participants were arrived at the laboratory at the same time (around 10:00 a.m.) in the morning after at least 10 h overnight fasting. Body weight (kg), body mass index (BMI, kg/m^2^), and body fat (%) were measured using a bioelectrical impedance method analyzer (Inbody 720, Biomedical, South Korea). The resting systolic blood pressure (SBP), diastolic blood pressure (DBP) from both arms and heart rate were measured in the seated position using an automated oscillometric blood pressure cuff (Ex-Plus 1300, Jawon Medical, South Korea).

Graded exercise test (GXT) {#sec2.3}
--------------------------

Maximum exercise testing was performed according to a Bruce protocol on a motor driven treadmill and maximal oxygen consumption was assessed in a controlled environment. Open circuit spirometry was used to assess cardiorespiratory fitness. The Bruce protocol is designed for healthy adults and this is a standard procedure of increasing speed and inclination on the treadmill. The initial load started at the speed of 1.7 miles per hour (mph) and an inclination of 10°. The speed was increased by approximately 0.8--0.9 mph and the slope was increased by 2° every 3 min whenever each step was done. Before each exercise session was initiated, we calibrated pneumotachometer and gas analysis according to manufacturer\'s instruction. A tightly sealed breathing mask connected to the airflow sensor was used. During the GXT, the oxygen uptake (VO~2~), carbon dioxide production (VCO~2~), pulmonary ventilation (VE) and respiratory exchange ratio (RER) were measured breath-to-breath through a stationary gas analyzer (Quark b2, COSMED, Germany). The maximal exercise test was continued until the subject voluntarily stopped. Blood lactate concentration was measured for VO~2max~ determination using an Accutrend Plus (Mannheim, Germany) before and after the GXT.

Blood analysis {#sec2.4}
--------------

Whole blood (35 μl) were collected from the fingertips after lancing the palm-side surface of a finger with lancet. Fasting blood glucose, triglycerides, high density lipoprotein (HDL), low density lipoprotein (LDL) and total cholesterol were immediately measured using a Cholestech LDX (Alere, Norway) according to manufacturer\'s protocol. In addition, 1.5 μl of whole blood was obtained from the fingertip and HbA1c was measured using an Afinion AS100 (Ballybrit Galway, Ireland).

Measurement of arterial stiffness {#sec2.5}
---------------------------------

Pulse wave velocity (PWV) is a clinical method to measure arterial stiffness. PWV is usually assessed by measuring the time taken for a pulse wave to move a specified distance and is increased as arterial stiffness augments. baPWV, a validated arterial stiffness measurement, was assessed the supine position using a non-invasive device after 10 min of quiet rest according to manufacturer\'s protocol using a VP-1000 plus (Omron, Japan) by bilaterally collecting the brachial and the posterior tibialis (ankle) artery blood pressure.[@bib19] Occlusion and cuffs were wrapped around both sides of the brachia and ankles and volume waveforms for the extremity were stored and analyzed automatically.

Statistical analyses {#sec2.6}
--------------------

All data were presented as mean ± SD. Pearson\'s correlations were used to determine the relationships between measurement variables. We used paired *t*-test to determine the differences in circulating lactate concentration before and after the GXT. In addition, we used independent *t*-test to determine the differences in parameters between men and women. Statistical analyses were conducted using the GraphPad Prism version 6.05 (La Jolla, CA, USA). Statistical difference was considered significant at the P \< 0.05 level.

Results {#sec3}
=======

Basic clinical characteristics {#sec3.1}
------------------------------

[Table 1](#tbl1){ref-type="table"} illustrates the basic characteristics of the study population. The study included 13 men aged 22.9 ± 0.7 years and 10 women aged 23.6 ± 0.4 years. Most of variables including age, BMI, total/HDL/LDL cholesterol, triglycerides, fasting glucose, HbA1c, right SBP and DBP, heart rate were comparable between male and female subjects. We confirmed that all subjects did not have overt cardiometabolic disease. As we anticipated, the male participants were taller and had greater weight and VO~2max~ than female participants, whereas female had higher body fat than male subjects. Further, male had higher left SBP (p = 0.004) and DBP (p = 0.02) than female, whereas right SBP and DBP were comparable. Consistent with a previous study,[@bib20] both right (p = 0.0177) and left (p = 0.031) baPWV were significantly lower in female compared to male subjects.Table 1Basic characteristics of male and female subjects.Table 1VariableMale (n-13)Female (n-10)P valueAge (year)22.9 ± 0.723.6 ± 0.40.4489Height (cm)176.5 ± 1.1162.3 ± 2.0\<0.0001Weight (kg)72.1 ± 2.356.3 ± 3.80.0012BMI(%)23.1 ± 0.621.2 ± 1.00.0985Body fat (%)12.8 ± 0.925.0 ± 0.9\<0.0001Total cholesterol (mg/dL)148.4 ± 6.2152.6 ± 8.70.6901HDL (mg/dL)59.3 ± 2.471.2 ± 7.10.0946LDL (mg/dL)71.8 ± 5.163.7 ± 6.60.3529Triglycerides (mg/dL)69.2 ± 6.594.0 ± 13.40.0883Fasting glucose (mg/dL)84.8 ± 2.992.7 ± 5.70.1975HbA1c (%)5.4 ± 0.15.2 ± 0.10.1729SBP(L)/mmHg123.0 ± 3.3108.3 ± 3.00.004DBP(L)/mmHg71.8 ± 3.062.1 ± 1.90.02SBP(R)/mmHg122.3 ± 4.5113.9 ± 3.30.1663DBP(R)/mmHg67.7 ± 2.464.4 ± 2.30.3378Pulse rate (bpm)75.2 ± 2.576.9 ± 4.00.7046R-PWV(m/s)1123.2 ± 47.8958.3 ± 38.10.0177L-PWV(m/s)1119.2 ± 36.8988.0 ± 43.60.031VO2max (ml/kg/min)55.2 ± 2.640.4 ± 2.60.0008Lactate (before, mmol/L)2.6 ± 0.32.5 ± 0.3--Lactate (after, mmol/L)11.0 ± 1.113.0 ± 1.3--[^2][^3]

Blood lactate {#sec3.2}
-------------

The blood lactate concentration was significantly elevated after GXT exercise in both men and women ([Table 1](#tbl1){ref-type="table"}).

Correlation between left and right baPWV {#sec3.3}
----------------------------------------

We assessed the relationship between left and right baPWV in male (r = 0.9739) and female (r = 0.9642) subjects, respectively ([Fig. 1](#fig1){ref-type="fig"}). Because there was no significant difference between right and left baPWV (p = 0.8), we used a mean right/left baPWV value for further analysis.Fig. 1Correlation between left and right baPWV in male(A) and female(B) subjects. There were the positive relationships between left and right PWV in both Male (n = 13) and female (n = 10).PWV, pulse wave velocity.Fig. 1

Correlation analysis between all measurements {#sec3.4}
---------------------------------------------

The correlation analysis between all measurements are shown in [Table 2](#tbl2){ref-type="table"} and [Fig. 2](#fig2){ref-type="fig"}. Specifically, total cholesterol correlated significantly to variables such as LDL ([Fig. 2](#fig2){ref-type="fig"}A, r = −0.63, p = 0.0018) and HDL cholesterol ([Fig. 2](#fig2){ref-type="fig"}B, r = 0.59, p = 0.001). Interestingly, VO~2max~ had an inverse association with triglyceride ([Fig. 2](#fig2){ref-type="fig"}C, r = −0.55, p = 0.0033), whereas VO~2max~ had no significant correlation with baPWV ([Fig. 2](#fig2){ref-type="fig"}D, r = 0.17, p = 0.2168).Table 2Results of Pearson\'s correlation analysis.Table 2Variablesr-ValuesTotal-CHDLLDLTGFasting glucoseHbA1cVO2maxRL-PWVTotal-C0.59\*\*−0.63\*\*0.05−0.04−0.08−0.090.3HDL−0.32−0.02−0.09−0.13−0.25−0.07LDL0.370.190.3−0.18−0.26TG0.160.13−0.24−0.22Fasting glucose0.19−0.24−0.22HbA1c0.1−0.6VO2max0.17RL-PWV[^4]Fig. 2Relation between Total-C and LDL-C (A) or HDL-C (B). Relation between VO~2max~ and triglycerides (C) or ba-PWV (D). There was a significant correlation between Total C and LDL-C and HDL-C. And there was a correlation between VO~2max~ and triglycerides, whereas baPWV had no significant correlation with VO~2max~ (n = 23).HDL, high density lipoprotein; LDL, low density lipoprotein; Total-C, total cholesterol; ba-PWV, brachial-ankle pulse wave velocity.Fig. 2

Discussion {#sec4}
==========

Previous studies have indicated there was an inverse relationship between cardiorespiratory fitness and arterial stiffness in the middle aged obese women and endurance athletes, suggesting individuals with higher cardiorespiratory fitness may have less possibility to develop arterial stiffness subsequently a reduction to cardiovascular mortality risk.[@bib17]^,^[@bib21] In this regard, we hypothesized that our study would show similar findings in healthy young adults. However, in this study there was no relationship between arterial stiffness and aerobic capacity in healthy young adults ([Fig. 2](#fig2){ref-type="fig"}D).

Augustine et al. showed that VO~2max~ was negatively associated with cf-PWV in middle aged obese women.[@bib17] In addition, Vaitkevicius et al. indicated that arterial stiffness increased with aging, suggesting arterial compliance may be affected by some pathological conditions such as obesity, hypertension and advancing age.[@bib5]

In a recent study, an inverse correlation between arterial stiffness (baPWV) and aerobic capacity was statistically significant in various range of age group (18--64 years) in 82 healthy men.[@bib6] However, the results of our study were different from the previous study because our study was conducted with only healthy young men (22.9 ± 0.7 years) and women (23.6 ± 0.4 years). Generally, VO~2max~ decreases gradually with advancing age, and the rate of decline is approximately 10% per decade after the age of 25 years.[@bib22]^,^[@bib23] Both the arterial stiffening and VO~2max~ decline occur as a consequence of aging. In this reason, we may not find significant association in this study because most of our young participants had relatively good arterial compliance and VO~2max~. Therefore, it may be necessary to investigate the correlation between arterial stiffness and VO~2max~ in older rather than young adults. In addition, Vaitkevicius et al. indicated that intervention such as regular endurance exercise may reduce arterial stiffness in aging population.[@bib5] Taken together, this suggests increased obesity and hypertension may lead to arterial stiffness as maximal aerobic capacity declines with age. For this reason, this finding suggests that maintenance and enhancement of maximal oxygen uptake by exercise may be an important factor in vascular health. Therefore, it is plausible to conclude that regular exercise may ameliorate arterial stiffness induced by some pathophysiological conditions including metabolic dysfunction and aging.

Another issue to consider is that different methods to measure arterial stiffness were used in these studies. Generally, there are two ways to measure arterial stiffness. cf-PWV measured by Doppler flowmeter or applanation tonometry is considered as the gold standard method for evaluating aortic stiffness.[@bib24]^,^[@bib25] Alternatively, baPWV has received great attention because of convenience of use for large-scale population studies and high association with CVD risk factors.[@bib20]^,^[@bib26], [@bib27], [@bib28], [@bib29] Elevation of baPWV has an association with augmented cf-PWV and increased baPWV may be an independent predictor of all-cause mortality in the general population.[@bib27]^,^[@bib28]^,^[@bib30] Thus, the baPWV may be considered as a reasonable and convenient method to replace cf-PWV.

In our study, we found that aerobic capacity had an only significant association with triglyceride level in healthy subjects. Overweight is associated with lower levels of physical activity and physical function in older population.[@bib31] Also, oxygen consumption per kilogram of body weight declined as fatness increased in adolescent females.[@bib32] Furthermore, Augustine et al. suggested that higher maximal oxygen consumption may indirectly reduce aortic stiffness through beneficial effects on CVD risk factors including insulin resistance.[@bib17] In a previous animal study, the low aerobic capacity runners had more visceral adiposity, higher plasma triglycerides, and elevated plasma free fatty acids compared with the high aerobic capacity runners in rat.[@bib33] Taken together, these studies support the notion that impaired lipid metabolism may link poor aerobic capacity to cardiometabolic risk factors. Additional studies are needed to investigate the relationship between dyslipidemia and arterial stiffness.

There are a few considerations in this study. First, we did not control menstrual cycle in our female subjects because fluctuating female sex hormones do not appear to influence arterial stiffness based on previous studies.[@bib34], [@bib35], [@bib36] However, some studies showed that arterial stiffness underwent major changes during the menstrual cycle.[@bib36]^,^[@bib37] In future study, it may be needed to control menstrual cycle for female participants. Second, as a pilot study, our study included only 23 young healthy adults (13 men and 10 women, respectively). For this reason, our findings could not be generalized to all healthy young adults.

Conclusion {#sec5}
==========

The study results indicated that there was no relationship between arterial stiffness and maximal aerobic capacity in healthy young adults. Because young participants had relatively good maximal aerobic capacity and arterial compliance, it appeared to be difficult to find an inverse relationship between arterial stiffness and maximal aerobic capacity.
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[^1]: Contributed equally to conduct of the studies.

[^2]: Values are means ± SD.

[^3]: BMI, body mass index; DBP, diastolic blood pressure; HbA1c, hemoglobin A1c; HDL, high density lipoprotein; L, left; LDL, low density lipoprotein; PWV, pulse wave velocity; R, right; SBP, systolic blood pressure; VO~2max~, maximal oxygen consumption.

[^4]: The correlation analysis between all measurements. HbA1c, hemoglobin A1c; HDL, high density lipoprotein; LDL, low density lipoprotein; TG, triglycerides; Total-C, total cholesterol; RL-PWV, mean of right and left pulse wave velocity; VO~2max~, maximal oxygen consumption. \*p \< 0.05 \*\*p \< 0.01.
